<SEC-DOCUMENT>0001047469-19-005496-index.html : 20190927
<SEC-HEADER>0001047469-19-005496.hdr.sgml : 20190927
<ACCEPTANCE-DATETIME>20190927163210
ACCESSION NUMBER:		0001047469-19-005496
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20190927
DATE AS OF CHANGE:		20190927

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-233717
		FILM NUMBER:		191122460

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>a2239777z424b4.htm
<DESCRIPTION>424B4
<TEXT>
Document 1 - file: a2239777z424b4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g839738.jpg
<DESCRIPTION>G839738.JPG
<TEXT>
Document 2 - file: g839738.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g85175.jpg
<DESCRIPTION>G85175.JPG
<TEXT>
Document 3 - file: g85175.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g227642.jpg
<DESCRIPTION>G227642.JPG
<TEXT>
Document 4 - file: g227642.jpg

</DOCUMENT>
</SEC-DOCUMENT>